Licata Maria Angela, Mencarini Paola, Mastrobattista Annelisa, Carli Serena Maria, Cerva Carlotta, Mosti Silvia, Libertone Raffaella, Zolezzi Alberto, Vittozzi Pietro, Nisii Carla, Mazzarelli Antonio, Cannas Angela, Navarra Assunta, Ianniello Stefania, Trisolini Rocco, Goletti Delia, Palmieri Fabrizio, Gualano Gina
Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.
Department of Microbiology, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.
Pathogens. 2024 Dec 3;13(12):1064. doi: 10.3390/pathogens13121064.
Diagnosing non-tuberculous mycobacterial pulmonary disease (NTM-PD) in patients unable to produce sputum spontaneously requires invasive procedures to obtain valid respiratory specimens. In this retrospective study, we evaluated the results of microbiological tests performed on respiratory samples of 132 patients affected by NTM-PD. In the diagnostic workout, 98 patients performed both induced sputum (IS) and bronchoalveolar lavage (BAL) and were enrolled in our study. A total of 93 out of 98 BAL samples (95%) were culture-positive for mycobacteria, whereas only 67/153 (44%) induced sputum cultures were positive for NTM ( < 0.001). Molecular identification of NTM with real-time polymerase chain reaction (PCR) was positive in 48/64 BAL (75%) and in 47/139 (34%) IS samples ( < 0.001). Patients affected by nodular-bronchiectatic form were 65/98 (66%): BAL culture was positive in 95% of cases (62/65 BAL), while only 30/99 IS cultures were positive (30%; < 0.001). PCR was positive in 76% of BAL samples examined (26/34) and in 26% of the IS samples (24 out of 91) ( < 0.001). Among 33 patients with a fibro-cavitary radiological pattern, 65% of IS (35/54) were culture-positive for NTM, whereas 94% of cases (31/33) had a positive culture for NTM from BAL ( = 0.002). PCR was positive in 73% of BAL samples tested (22/30) and 48% of IS samples tested (23/48) ( = 0.031). Our results confirm BAL mycobacterial culture as the gold standard for the diagnosis of pulmonary mycobacteriosis. FBS with BAL should be performed in every patient with a strong suspicion of NTM-PD, if other respiratory samples are repeatedly negative. Sputum induction is a useful technique to obtain valid respiratory samples when patients are unable to produce spontaneous sputum, especially in the outpatient setting. However, during the diagnostic workup of NTM-PD, we should not forget that PCR and mycobacterial culture of induced sputum have a lower yield than when performed on BAL, especially in the nodular-bronchiectatic form of the disease.
对于无法自行咳出痰液的患者,诊断非结核分枝杆菌肺病(NTM-PD)需要采用侵入性操作来获取有效的呼吸道标本。在这项回顾性研究中,我们评估了对132例NTM-PD患者呼吸道样本进行的微生物学检测结果。在诊断过程中,98例患者同时进行了诱导痰(IS)和支气管肺泡灌洗(BAL),并纳入我们的研究。98份BAL样本中共有93份(95%)结核分枝杆菌培养呈阳性,而153份诱导痰培养中只有67份(44%)NTM呈阳性(<0.001)。采用实时聚合酶链反应(PCR)对NTM进行分子鉴定,在48/64份BAL样本(75%)和47/139份IS样本(34%)中呈阳性(<0.001)。患有结节性支气管扩张型的患者有65/98例(66%):BAL培养在95%的病例中呈阳性(62/65份BAL),而只有30/99份IS培养呈阳性(30%;<0.001)。在所检测的BAL样本中,76%(26/34)的PCR呈阳性,而IS样本中26%(91份中的24份)呈阳性(<0.001)。在33例具有纤维空洞型放射学模式的患者中,65%的IS样本(35/54)NTM培养呈阳性,而94%的病例(31/33)BAL的NTM培养呈阳性(P = 0.002)。在所检测的BAL样本中,73%(22/30)的PCR呈阳性,48%的IS样本(23/48)呈阳性(P = 0.031)。我们的结果证实BAL结核分枝杆菌培养是诊断肺部分枝杆菌病的金标准。对于每一位高度怀疑NTM-PD但其他呼吸道样本反复阴性的患者,都应进行BAL联合FBS检查。当患者无法自行咳出痰液时,诱导痰是获取有效呼吸道样本的有用技术,尤其是在门诊环境中。然而,在NTM-PD的诊断过程中,我们不应忘记,诱导痰的PCR和结核分枝杆菌培养的阳性率低于对BAL样本进行检测时的阳性率,尤其是在疾病的结节性支气管扩张型中。